RESUMEN

Given the critical importance, resource limination and environmental toxicity of phosphorus, the study of phosphorus recovery and utilization is extremely urgent. This paper utilized unmodified oyster shell powder (OSP) and cotton fibers as raw materials to prepare OSP-loaded cellulose gel beads (OSP@Gel) through the fiber-dissolving capability of LiBr·3H2O molten salt, for phosphate recovery from water. The surface microstructure and chemical properties of OSP@Gel were characterized by using Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS), confirming the loading of OSP onto the gel matrix. The phosphorus adsorption capacity of a single OSP@Gel bead could reach up to 8.80 ± 0.32 mg at the optimal OSP doping amount of 1.0 g and optimal pH of 5.0. Kinetic and isotherm analyses revealed that the experimental data fit the PSO model and the Langmuir model. Thermodynamic analysis suggested that the phosphate adsorption was endothermic. Combined results from SEM and XPS analyses indicated that the adsorption of phosphate by OSP@Gel was chemical, with adsorption rate controlled by both liquid film diffusion and intraparticle diffusion. The high phosphate adsorption capacity, good mechanical stability in water, and easy degradability in plant soil provide OSP@Gel beads with great potential for phosphate recovery.

RESUMEN

AIM: To evaluate the effects of bariatric arterial embolization (BAE) on gastric emptying of, and the glycaemic response to, an oral glucose load in an obese canine model with impaired glucose tolerance. METHODS: Eleven male dogs were fed a high-fat, high-fructose diet for 7 weeks before receiving BAE, which involved selective embolization of the left gastric artery (n = 5; 14.9 ± 0.8 kg), or the sham (n = 6; 12.6 ± 0.8 kg) procedure. Postprocedural body weight was measured weekly for 4 weeks. Prior to and at 4 weeks postprocedure, a glucose solution containing 13C-acetate was administered orally for evaluation of the gastric half-emptying time (T50) and the glycaemic response. The relationship between the changes in the blood glucose area under the curve over the first 60 minutes (AUC0-60min) and the T50 was also assessed. RESULTS: At 4 weeks postprocedure, BAE reduced body weight (BAE vs. the sham procedure: -5.7% ± 0.9% vs. 3.5% ± 0.9%, P < .001), slowed gastric emptying (T50 at baseline vs. postprocedure: 75.5 ± 2.0 vs. 82.5 ± 1.8 minutes, P = .021 in the BAE group; 73.8 ± 1.8 vs. 74.3 ± 1.9 minutes in the sham group) and lowered the glycaemic response to oral glucose (AUC0-60min at baseline vs. postprocedure: 99.2 ± 13.7 vs. 67.6 ± 9.8 mmol·min/L, P = .043 in the BAE group; 100.2 ± 13.4 vs. 103.9 ± 14.6 mmol·min/L in the sham group). The change in the glucose AUC0-60min correlated inversely with that of the T50 (r = -0.711; P = .014). CONCLUSIONS: In a canine model with impaired glucose tolerance, BAE, while reducing body weight, slowed gastric emptying and attenuated the glycaemic response to an oral glucose load.

Asunto(s)

RESUMEN

The rising prevalence of metabolic disorders such as obesity and type 2 diabetes mellitus (T2DM) poses a major challenge to global health. Existing therapeutic approaches have limitations, and there is a need for new, safe, and less invasive treatments. Interventional metabolic therapy is a new addition to the treatment arsenal for metabolic disorders. This review focuses on two interventional techniques: bariatric arterial embolization (BAE) and endovascular denervation (EDN). BAE involves embolizing specific arteries feeding ghrelin-producing cells to suppress appetite and promote weight loss. EDN targets nerves that regulate metabolic organs to improve glycemic control in T2DM patients. We describe the current state of these techniques, their mechanisms of action, and the available safety and effectiveness data. We also propose a new territory called "Interventional Metabology" to encompass these and other interventional approaches to treating metabolic disorders.

Asunto(s)